The Investigation of Somatostatin Receptors As a Potential Target in Breast Phyllodes Tumours

Overview

Journal Diagnostics (Basel)

Specialty Radiology

Date 2025 Jan 8

PMID 39767203

Authors

Hande Suer Mickler

Murat Mert Erkan

Affiliations

Soon will be listed here.

Abstract

Background: Somatostatin receptors (SSTRs) are expressed in most neuroendocrine neoplasms, particularly in gastroenteropancreatic neuroendocrine tumours, and have been utilised as diagnostic markers and therapeutic targets. The radioiodinated somatostatin analogue 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid- Tyr3-octreotate (DOTATATE) has been employed for SSTR targeting for either diagnostic or therapeutic purposes depending on the labelling with Gallium or Lutetium, respectively. SSTR expression is reported in a subset of breast adenocarcinoma and breast neuroendocrine carcinomas; however, minimal knowledge exists regarding their expression in fibroepithelial (biphasic) breast lesions such as fibroadenoma and phyllodes tumours. Aggressive ends of the spectrum, i.e., "cystosarcoma phyllodes", may present a management challenge with recurrences and metastases, and SSTRs could be a promising therapeutic target for these types of tumours.

Methods: Gene and protein expressions of SSTRs in primary human fibroepithelial lesions of the breast are investigated using RT-PCR and immunoblotting. Localisation of the SSTR-positive cells was determined with immunohistochemistry and immunofluorescence.

Results And Conclusions: Both fibroadenoma and phyllodes tumours express SSTRs. Immunohistochemical analyses suggested that this expression is in the stromal, not epithelial, component by demonstrating that SSTR stained in the areas overlapping with α-smooth muscle actin-positive myoepithelial cells around blood vessels and capillary structures. This study is the first in the literature to demonstrate SSTR positivity in mammary fibroepithelial neoplasms. Once validated, these findings may also have significant implications for managing the treatment of these tumours.

References

Bergers G, Song S, Meyer-Morse N, Bergsland E, Hanahan D . Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest. 2003; 111(9):1287-95. PMC: 154450. DOI: 10.1172/JCI17929. View

Kumar U, Grigorakis S, Watt H, Sasi R, Snell L, Watson P . Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1--5 and correlation with receptor protein expression and tumor pathology. Breast Cancer Res Treat. 2005; 92(2):175-86. DOI: 10.1007/s10549-005-2414-0. View

Bergers G, Hanahan D . Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer. 2008; 8(8):592-603. PMC: 2874834. DOI: 10.1038/nrc2442. View

Gudjonsson T, Adriance M, Sternlicht M, Petersen O, Bissell M . Myoepithelial cells: their origin and function in breast morphogenesis and neoplasia. J Mammary Gland Biol Neoplasia. 2006; 10(3):261-72. PMC: 2798159. DOI: 10.1007/s10911-005-9586-4. View

Hu Y, Ye Z, Wang F, Qin Y, Xu X, Yu X . Role of Somatostatin Receptor in Pancreatic Neuroendocrine Tumor Development, Diagnosis, and Therapy. Front Endocrinol (Lausanne). 2021; 12:679000. PMC: 8170475. DOI: 10.3389/fendo.2021.679000. View

Frati A, Rouzier R, Lesieur B, Werkoff G, Antoine M, Rodenas A . Expression of somatostatin type-2 and -4 receptor and correlation with histological type in breast cancer. Anticancer Res. 2014; 34(8):3997-4003. View

Pilichowska M, Kimura N, Schindler M, Suzuki A, Yoshida R, Nagura H . Expression of somatostatin type 2A receptor correlates with estrogen receptor in human breast carcinoma. Endocr Pathol. 2004; 11(1):57-67. DOI: 10.1385/ep:11:1:57. View

Nguyen Q, Pervolarakis N, Blake K, Ma D, Davis R, James N . Profiling human breast epithelial cells using single cell RNA sequencing identifies cell diversity. Nat Commun. 2018; 9(1):2028. PMC: 5966421. DOI: 10.1038/s41467-018-04334-1. View

Gao J, Wen S, Feng S, Yang W, Lu Y, Tong H . Celecoxib and octreotide synergistically ameliorate portal hypertension via inhibition of angiogenesis in cirrhotic rats. Angiogenesis. 2016; 19(4):501-11. PMC: 5026725. DOI: 10.1007/s10456-016-9522-9. View

10.

Aslam M, Idrees H, Ferdinandy P, Helyes Z, Hamm C, Schulz R . Somatostatin Primes Endothelial Cells for Agonist-Induced Hyperpermeability and Angiogenesis In Vitro. Int J Mol Sci. 2022; 23(6). PMC: 8949535. DOI: 10.3390/ijms23063098. View

11.

Yan S, Li M, Chai H, Yang H, Lin P, Yao Q . TNF-alpha decreases expression of somatostatin, somatostatin receptors, and cortistatin in human coronary endothelial cells. J Surg Res. 2005; 123(2):294-301. DOI: 10.1016/j.jss.2004.07.244. View

12.

Hofman M, Lau W, Hicks R . Somatostatin receptor imaging with 68Ga DOTATATE PET/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation. Radiographics. 2015; 35(2):500-16. DOI: 10.1148/rg.352140164. View

13.

Kwekkeboom D, Krenning E . Somatostatin receptor imaging. Semin Nucl Med. 2002; 32(2):84-91. DOI: 10.1053/snuc.2002.31022. View

14.

Suer H, Erus S, Cesur E, Yavuz O, Agcaoglu O, Bulutay P . Combination of CEACAM5, EpCAM and CK19 gene expressions in mediastinal lymph node micrometastasis is a prognostic factor for non-small cell lung cancer. J Cardiothorac Surg. 2023; 18(1):189. PMC: 10262366. DOI: 10.1186/s13019-023-02297-z. View

15.

Curtis S, Chen J, Winkelaar G, Turnbull R, Hewitt J, Buchan A . Effect of endothelial and adventitial injury on somatostatin receptor expression. Surgery. 2000; 127(5):577-83. DOI: 10.1067/msy.2000.105027. View

16.

Benali N, Ferjoux G, Puente E, Buscail L, Susini C . Somatostatin receptors. Digestion. 2000; 62 Suppl 1:27-32. DOI: 10.1159/000051852. View

17.

Mayr C, Simon L, Leuschner G, Ansari M, Schniering J, Geyer P . Integrative analysis of cell state changes in lung fibrosis with peripheral protein biomarkers. EMBO Mol Med. 2021; 13(4):e12871. PMC: 8033531. DOI: 10.15252/emmm.202012871. View

18.

Arne G, Nilsson B, Dalmo J, Kristiansson E, Arvidsson Y, Forssell-Aronsson E . Gastrointestinal stromal tumors (GISTs) express somatostatin receptors and bind radiolabeled somatostatin analogs. Acta Oncol. 2012; 52(4):783-92. DOI: 10.3109/0284186X.2012.733075. View

19.

Curtis S, Hewitt J, Yakubovitz S, ANZARUT A, Hsiang Y, Buchan A . Somatostatin receptor subtype expression and function in human vascular tissue. Am J Physiol Heart Circ Physiol. 2000; 278(6):H1815-22. DOI: 10.1152/ajpheart.2000.278.6.H1815. View

20.

Chereau E, Durand L, Frati A, Prignon A, Talbot J, Rouzier R . Correlation of immunohistopathological expression of somatostatin receptor-2 in breast cancer and tumor detection with 68Ga-DOTATOC and 18F-FDG PET imaging in an animal model. Anticancer Res. 2013; 33(8):3015-9. View